ICICI Prudential Nifty Pharma Index Fund
What This Strategy Does
CW Expert Research Notes
Consistent Outperformance
The fund has demonstrated resilient benchmark-relative behavior, outperforming in 10 out of 12 years, showcasing its ability to deliver consistent earnings participation and downside protection across market cycles.
Concentrated Pharma Exposure
With a differentiated process focused solely on the pharmaceutical sector, the fund offers a distinct weighting bias compared to peers, exemplified by its 100% allocation to healthcare and overweight positions in industry leaders like Sun Pharmaceutical and Dr. Reddy's Laboratories.
Defensive Portfolio Role
Positioned as a defensive holding, the fund's low-beta profile and reasonable valuation could provide portfolio resilience amid potential headwinds from regulatory scrutiny or pricing pressures, while benefiting from structural growth trends in the Indian pharmaceutical market.
Performance and Risk Analysis
Historical returns, volatility patterns, and how this fund has performed relative to its benchmark.
Fund Performance
Benchmark Performance Comparison
Risk Profile
Detailed Risks
Market Risk
Potential recession or demand contraction in key export markets could undermine pharma earnings.
Liquidity Risk
Concentrated mid-cap exposure could amplify liquidity stress during volatility spikes.
Concentration Risk
Significant sector concentration in pharma exposes fund to regulatory pricing pressures.
Specific Strategy Risk
Index tracking limits ability to mitigate pharma-specific risks like patent expirations.
Strategy Details
A closer look at the investment thesis, portfolio construction, and current holdings.
Core Investment Theme
Provides targeted exposure to India's pharmaceutical sector—companies at the forefront of developing affordable drugs and treatments. This theme captures the nation's growing role as a global healthcare hub, driven by cost advantages, robust R&D capabilities, and rising domestic demand from an expanding middle class.
Broader Market View
Market Outlook
Why This Strategy is Attractive Now
Investment Style & Process
Investment Style
Why it Makes Sense
High-Level Investment Process
Portfolio Holdings Overview
Geographic Allocation
Top Stock Holdings
Fund House Management
The asset management company’s track record, AUM scale, and fund manager credentials.
Fund Manager Track Record
Nishit Patel
Mr. Nishit Patel has experience of 8 years. Manages 220 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr Holds a B.Com degree.
10 years
Combined Team Experience
₹ 188 Cr
Assets Under Management
Ashwini Bharucha
Co-Portfolio ManagerAshwini Bharucha has experience of 2 years. Manages 212 funds at ICICI Prudential Asset Management Co Ltd with an AUM of approximately ₹94 Cr
CW Expert Take
ICICI Prudential Nifty Pharma Index Fund tracks the Nifty Pharma Index, providing exposure to India's pharmaceutical sector. The fund maintains a disciplined approach, replicating the index composition through passive management. Its concentrated portfolio reflects the healthcare-focused mandate, with allocations driven by index weightings across market capitalizations.
Investment Philosophy & Approach
Disciplined Indexing
The fund employs a passive strategy to replicate the Nifty Pharma Index.
Diversified Exposure
It provides diversified exposure to the pharmaceutical sector through a basket approach.
Low-Cost Investing
The fund aims to minimize tracking error while keeping costs low.
Operational & Regulatory Details
What it costs to invest, transaction mechanics, and regulatory disclosures you should know.
Costs and Fees
Regulatory & Tax Information
LTCG | >1Year 12.5%% on gain above 1.25 Lakh
STCG | <1Year 20%%
Tax Implications (India)